Insider · CIK 0001838112

Mancini Marianna

Reports to the SEC for 1 company · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001838112

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-29	VKTXViking Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−18.2K sh	$33.47	−$610K	422,760
2026-07-28	VKTXViking Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+31.7K sh	—	—	440,977
2026-01-05	VKTXViking Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−32K sh	$32.29	−$1.03M	434,890
2026-01-05	VKTXViking Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−10.5K sh	$34.22	−$359K	410,790
2026-01-05	VKTXViking Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−13.6K sh	$33.37	−$454K	421,290
2026-01-05	VKTXViking Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−1,600 sh	$35.07	−$56.1K	409,190
2026-01-02	VKTXViking Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+32K sh	—	—	466,851
2026-01-02	VKTXViking Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+41K sh	—	—	434,802
2026-01-02	VKTXViking Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+91K sh	—	—	91,000
2025-10-28	VKTXViking Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−6,185 sh	$35.00	−$216K	382,467
2025-10-27	VKTXViking Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+11.1K sh	—	—	388,652
2025-07-03	VKTXViking Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−4,266 sh	$27.77	−$118K	377,535
2025-07-02	VKTXViking Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+7,667 sh	—	—	381,801
2025-01-06	VKTXViking Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−5,100 sh	$43.32	−$221K	374,134
2025-01-06	VKTXViking Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−49.1K sh	$42.69	−$2.1M	379,234
2025-01-03	VKTXViking Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+37.2K sh	—	—	37,200
2025-01-03	VKTXViking Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+21.7K sh	—	—	428,349
2025-01-03	VKTXViking Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+44.5K sh	—	—	406,682
2024-07-30	VKTXViking Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−3,322 sh	$57.82	−$192K	362,149
2024-07-30	VKTXViking Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−14.7K sh	$56.98	−$838K	365,471
2024-07-29	VKTXViking Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+21.7K sh	—	—	380,175
2024-07-29	VKTXViking Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+10K sh	—	—	358,508
2024-05-01	VKTXViking Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+87K sh	$4.88	+$425K	453,507
2024-05-01	VKTXViking Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−51K sh	—	—	153,000
2024-05-01	VKTXViking Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−35.4K sh	—	—	18,574
2024-05-01	VKTXViking Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−90K sh	—	—	0
2024-05-01	VKTXViking Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−87K sh	—	—	87,000
2024-05-01	VKTXViking Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−18K sh	—	—	1
2024-05-01	VKTXViking Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−6,248 sh	$80.08	−$500K	348,508
2024-05-01	VKTXViking Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−120K sh	$79.29	−$9.51M	354,756
2024-05-01	VKTXViking Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−105K sh	$78.65	−$8.28M	474,702
2024-05-01	VKTXViking Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−26.1K sh	$77.49	−$2.03M	580,045
2024-05-01	VKTXViking Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−23.7K sh	$76.40	−$1.81M	606,187
2024-05-01	VKTXViking Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+51K sh	$8.52	+$435K	629,933
2024-05-01	VKTXViking Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+35.4K sh	$7.77	+$275K	578,933
2024-05-01	VKTXViking Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+90K sh	$5.80	+$522K	543,507
2024-05-01	VKTXViking Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+18K sh	$4.68	+$84.2K	366,507
2024-03-27	VKTXViking Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−16.6K sh	$83.34	−$1.38M	363,565
2024-03-27	VKTXViking Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+31.7K sh	—	—	380,175
2024-03-01	VKTXViking Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−17K sh	$85.22	−$1.45M	348,508
2024-03-01	VKTXViking Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+31.7K sh	—	—	365,466
2024-01-04	VKTXViking Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−14.2K sh	$18.58	−$264K	333,799
2024-01-03	VKTXViking Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−16.5K sh	$17.40	−$288K	310,675
2024-01-03	VKTXViking Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+70K sh	—	—	380,675
2024-01-03	VKTXViking Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+28.3K sh	—	—	327,208
2024-01-03	VKTXViking Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+155K sh	—	—	155,000
2024-01-03	VKTXViking Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−32.7K sh	$17.40	−$569K	347,998
2023-04-17	VKTXViking Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−12.5K sh	—	—	0
2023-04-17	VKTXViking Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−12.5K sh	$20.00	−$250K	287,763
2023-04-17	VKTXViking Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+12.5K sh	$13.07	+$163K	300,263

Recent filings

Accepted (ET)
Jul 294
Mancini Marianna0001193125-26-324446
SEC(opens sec.gov)
Jan 54
Mancini Marianna0001193125-26-003115
SEC(opens sec.gov)
Oct 284
Mancini Marianna0001193125-25-254304
SEC(opens sec.gov)
Jul 34
Mancini Marianna0000950170-25-093791
SEC(opens sec.gov)
Jan 64
Mancini Marianna0000950170-25-002486
SEC(opens sec.gov)
Jul 314
Mancini Marianna0000950170-24-088537
SEC(opens sec.gov)

Companies

Viking Therapeutics, Inc.Chief Operating OfficerVKTX

Address

C/O VIKING THERAPEUTICS, INC. 9920 PACIFIC HEIGHTS BLVD, SUITE 350

SAN DIEGO, CA, 92121